Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 19, 2006

View Archived Issues

ATL-104 lessens mucositis in stem cell transplant patients

PKC-412 demonstrates activity in acute myeloid leukemia, systemic mastocytosis

EntreMed plans IND filing for novel multi-kinase inhibitor

NeurotrophinCell shows potential for prevention of type 1 diabetes

SGX-70393: A novel Bcr-Abl inhibitor with broad efficacy in vitro

Novozymes completes acquisition of GroPep

OSI grants Bristol-Myers Squibb license for DPP-IV inhibitors

AT-2220 begins phase I studies for Pompe disease

Kiadis Pharma formed through merger of Kiadis and Celmed

TNFerade phase II/III trial cleared to continue at interim analysis

Oral cannabinor completes preclinical toxicology and safety pharmacology studies

Forest Laboratories to acquire Cerexa

Novartis works to create new strategic growth platform in human vaccines

Roche files additional Mircera data

Peregrine and Biotecnol to develop novel targeted immunocytokine agents

PATH MVI partners with Sanaria on malaria vaccine

Bradmer discusses with FDA plans for pivotal study of Neuradiab in GBM

Pain perception blocked by SCN9A mutations / News in Context

Roscovitine shows promise in preclinical models of polycystic kidney disease

Novel CRH-R1 antagonist shows potential for the treatment of alcohol abuse

Recent patents impart new therapeutic agents for cancer

Recent CV Therapeutics patents impart novel adenosine A1 receptor agonists for atrial fibrillation

Tysabri sBLA filed for Crohn's disease

Positive opinion in E.U. in GSK's flu pandemic vaccine program

NDA filed for doripenem

European CHMP recommends conditional approval for Prezista in HIV

FDA approval for Bio-E-Gel, to be marketed as Elestrin

FDA approves Cyanokit for cyanide poisoning

ZymoGenetics seeks FDA approval for rhThrombin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.